- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...major pharmaceutical company, including at least 7 years in global medical safety. Oncology expertise is strongly preferred.Experience… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …new medicines to help people. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is ... in project management, process, product, and/or analytical development activities and oncology project development.Extensive knowledge of global CMC regulatory… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...business stakeholders of Corp. Function's, working closely with the Head of Global BRM and Global… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...regard to ways or working or resources to the Head of US Regulatory Affairs and/or Global … more
- AbbVie (Florham Park, NJ)
- …San Francisco, CA preferred. Will consider remote candidates. Purpose: + Lead global pipeline medical affairs strategy and develop compelling differentiation ... Therapeutic Area BU and Development + Represent TA in pipeline governance, where aligned with TA BU Head...in oncohematology, including contributions to peer-reviewed journals and major oncology conferences + Experience in managing global … more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...major pharmaceutical company, including at least 7 years in global medical safety. + Oncology expertise is… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …new medicines to help people. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is ... expertise in project management, process, product, and/or analytical development activities and oncology project development. + Extensive knowledge of global CMC… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...business stakeholders of Corp. Function's, working closely with the Head of Global BRM and Global… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...regard to ways or working or resources to the Head of US Regulatory Affairs and/or Global … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines ... Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas. MTPA's commitment… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines ... Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas. MTPA's commitment… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines ... Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas. MTPA's commitment… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines ... Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas. MTPA's commitment… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines ... Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas. MTPA's commitment… more
